CIK 0001478320 · Large accelerated filer
Adaptive Biotechnologies Corp
Sign in to watch- Ticker
- ADPT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- operating
- EIN
- 270907024
- Phone
- 206-659-0067
- Business address
- 1165 EASTLAKE AVE E, SEATTLE, WA, 98109
- Former names
- Adaptive TCR Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $32,383,812
- in 18 filings, $13.4M under 10b5-1 plans
Net −$32,383,812. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-10 | RUBINSTEIN JULIE President and COO | Option exercise 10b5-1 | +11,881 | $12.14 | $144K | 389,683 |
| 2026-11-10 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −9,981 | $29.35 | $293K | 379,702 |
| 2026-11-10 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −1,900 | $30.41 | $58K | 377,802 |
| 2026-11-10 | RUBINSTEIN JULIE President and COO | Option exercise · Stock Option (right to buy) 10b5-1 | −11,881 | 35,228 | ||
| 2026-11-09 | RUBINSTEIN JULIE President and COO | Option exercise 10b5-1 | +11,881 | $12.14 | $144K | 389,683 |
| 2026-11-09 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −1,100 | $28.87 | $32K | 388,583 |
| 2026-11-09 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −8,381 | $30.15 | $253K | 380,202 |
| 2026-11-09 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −2,400 | $30.58 | $73K | 377,802 |
| 2026-11-09 | RUBINSTEIN JULIE President and COO | Option exercise · Stock Option (right to buy) 10b5-1 | −11,881 | 47,109 | ||
| 2026-11-06 | RUBINSTEIN JULIE President and COO | Option exercise 10b5-1 | +11,881 | $12.14 | $144K | 389,683 |
| 2026-11-06 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −8,400 | $27.32 | $229K | 381,283 |
| 2026-11-06 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −3,481 | $27.88 | $97K | 377,802 |
| 2026-11-06 | RUBINSTEIN JULIE President and COO | Option exercise · Stock Option (right to buy) 10b5-1 | −11,881 | 58,990 | ||
| 2026-11-05 | RUBINSTEIN JULIE President and COO | Option exercise 10b5-1 | +11,881 | $12.14 | $144K | 389,683 |
| 2026-11-05 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −5,926 | $26.10 | $155K | 383,757 |
| 2026-11-05 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −5,455 | $26.88 | $147K | 378,302 |
| 2026-11-05 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −500 | $27.70 | $14K | 377,802 |
| 2026-11-05 | RUBINSTEIN JULIE President and COO | Option exercise · Stock Option (right to buy) 10b5-1 | −11,881 | 70,871 | ||
| 2026-11-04 | RUBINSTEIN JULIE President and COO | Option exercise 10b5-1 | +11,881 | $12.14 | $144K | 389,683 |
| 2026-11-04 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −4,000 | $25.78 | $103K | 385,683 |
Page 1 of 119 · 2,374 trades